Ara
Toplam kayıt 4, listelenen: 1-4
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
(TÜBİTAK, 2020-02-13)
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registry
(Clinical And Experimental Rheumatology S.A.S, 2019-08-14)
Objectives: To assess the real-life retention rate of certolizumab and factors related to retention of certolizumab.
Methods: We analysed all patients who received at least 1 dose of certolizumab and were registered in ...
Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study
(Springer, 2019-02-01)
Objective: To identify several clinical and/or laboratory parameters which can differentiate adult-onset Still's disease (AOSD) from other causes of fever of unknown origin (FUO) and create a clinician-friendly algorithm ...
Correction to: Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study
(Springer, 2019-04-01)
The author regrets that the original version of this article contained error. Figure 1 was shown in the wrong version, thus corrected figure is shown in this article.